Molecularly targeted therapy on a new preclinical mouse model for gastric neuroendocrine tumors
Neuroendocrine tumors are a heterogeneous group of malignancies with an increasing prevalence. Since there is not much progress in therapy, model systems are urgently needed. We have a CEA424-SV40 TAg transgenic mouse model which develops spontaneous tumors in the antral region of the stomach. In ad...
Main Author: | Pan, Jie |
---|---|
Format: | Others |
Published: |
Ludwig-Maximilians-Universität München
2013
|
Subjects: | |
Online Access: | http://edoc.ub.uni-muenchen.de/15934/1/Pan_Jie.pdf http://nbn-resolving.de/urn:nbn:de:bvb:19-159343 |
Similar Items
-
Functional characterization of FMNL1 as potential target for novel anti-tumor therapies
by: Han, Yanyan
Published: (2010) -
Membrane-anchored chemokine fusion proteins as adjuvants for tumor therapy
by: Münchmeier, Jan Niklas
Published: (2012) -
Genetically engineering mesenchymal stem cells for targeting tumor stroma and angiogenesis in hepatocellular carcinoma
by: Bao, Qi
Published: (2012) -
Characterization of murine pancreatic
carcinoma models regarding immunosuppressive mechanisms and therapy with bifunctional siRNA targeting galectin-1
by: Adunka, Tina
Published: (2014) -
Establishment of a mouse model with mutagenesis induced hyperaldosteronism
by: Spyroglou, Ariadni
Published: (2009)